IGF1 and malignant colon neoplasm: Our analyses using the public database also indicated that an increased IGF1 mRNA was identified in patients with colon cancer as well as a shorter survival time, as compared to patients with a lower IGF1 mRNA level; HT29 colon cancer cells resistant to methotrexate expressed a significantly higher level of IGF1 mRNA as compared to their sensitive counterparts.